$1.2599
0.1199[10.52%]
At close: Apr 12
$1.2599
0[0.00%]
PreMarket: 5:57PM EDT
Co-Diagnostics
(NASDAQ:CODX)Co-Diagnostics Stock (NASDAQ:CODX), Analyst Ratings, Price Targets, Predictions
Co-Diagnostics Inc has a consensus price target of $3.75, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on March 15, 2024, December 29, 2023, and November 13, 2023. With an average price target of $2.83 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 124.89% upside for Co-Diagnostics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Sidoti & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Co-Diagnostics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/15/2024 | CODX | Buy Now | Co-Diagnostics | $1.26 | 98.43% | HC Wainwright & Co. | Yi Chen | $3 → $2.5 | Maintains | Neutral | Get Alert |
| 12/29/2023 | CODX | Buy Now | Co-Diagnostics | $1.26 | 138.11% | HC Wainwright & Co. | Yi Chen | → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 11/13/2023 | CODX | Buy Now | Co-Diagnostics | $1.26 | 138.11% | HC Wainwright & Co. | Yi Chen | $2 → $3 | Maintains | Neutral | Get Alert |
| 08/14/2023 | CODX | Buy Now | Co-Diagnostics | $1.26 | 58.74% | HC Wainwright & Co. | Yi Chen | $3 → $2 | Maintains | Neutral | Get Alert |
| 05/15/2023 | CODX | Buy Now | Co-Diagnostics | $1.26 | 138.11% | HC Wainwright & Co. | Yi Chen | → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 03/20/2023 | CODX | Buy Now | Co-Diagnostics | $1.26 | 138.11% | HC Wainwright & Co. | Yi Chen | $6 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 02/23/2023 | CODX | Buy Now | Co-Diagnostics | $1.26 | 376.23% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | → Buy | Get Alert |
| 11/14/2022 | CODX | Buy Now | Co-Diagnostics | $1.26 | 376.23% | HC Wainwright & Co. | Yi Chen | $9 → $6 | Maintains | Buy | Get Alert |
| 08/15/2022 | CODX | Buy Now | Co-Diagnostics | $1.26 | 614.34% | HC Wainwright & Co. | Yi Chen | $12 → $9 | Maintains | Buy | Get Alert |
| 08/12/2022 | CODX | Buy Now | Co-Diagnostics | $1.26 | 296.86% | Sidoti & Co. | James Sidoti | → $5 | Downgrade | Buy → Neutral | Get Alert |
| 05/16/2022 | CODX | Buy Now | Co-Diagnostics | $1.26 | 852.46% | HC Wainwright & Co. | Yi Chen | $15 → $12 | Maintains | Buy | Get Alert |
| 11/12/2021 | CODX | Buy Now | Co-Diagnostics | $1.26 | 1090.57% | HC Wainwright & Co. | Yi Chen | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Co-Diagnostics (CODX)?
The latest price target for Co-Diagnostics (NASDAQ: CODX) was reported by HC Wainwright & Co. on March 15, 2024. The analyst firm set a price target for $2.50 expecting CODX to rise to within 12 months (a possible 98.43% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Co-Diagnostics (CODX)?
The latest analyst rating for Co-Diagnostics (NASDAQ: CODX) was provided by HC Wainwright & Co., and Co-Diagnostics maintained their neutral rating.
When was the last upgrade for Co-Diagnostics (CODX)?
There is no last upgrade for Co-Diagnostics.
When was the last downgrade for Co-Diagnostics (CODX)?
The last downgrade for Co-Diagnostics Inc happened on March 20, 2023 when HC Wainwright & Co. changed their price target from $6 to $3 for Co-Diagnostics Inc.
When is the next analyst rating going to be posted or updated for Co-Diagnostics (CODX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Co-Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Co-Diagnostics was filed on March 15, 2024 so you should expect the next rating to be made available sometime around March 15, 2025.
Is the Analyst Rating Co-Diagnostics (CODX) correct?
While ratings are subjective and will change, the latest Co-Diagnostics (CODX) rating was a maintained with a price target of $3.00 to $2.50. The current price Co-Diagnostics (CODX) is trading at is $1.26, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.